Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas

BMJ. 2016 Aug 5:354:i4328. doi: 10.1136/bmj.i4328.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Drug Administration Schedule
  • Drug Interactions
  • Glyburide / administration & dosage
  • Glyburide / adverse effects
  • Humans
  • Hypoglycemia / chemically induced*
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Sulfonylurea Compounds / administration & dosage
  • Sulfonylurea Compounds / adverse effects*
  • Warfarin / administration & dosage
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Warfarin
  • Glyburide